Read More

Recap: INmune Bio Q2 Earnings

INmune Bio (NASDAQ:INMB) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings INmune Bio beat estimated earnings by 24.0%, reporting an EPS of $-0.38 versus an estimate of $-0.5.

INMB